Bayer AG removed its antibleeding drug Trasylol (aprotinin) from the U.S. and worldwide markets after a Canadian clinical study found it could be linked to a higher risk of death than similar drugs. More recent studies have suggested the drug also raises the risk of death. The drug has been the subject of much debate after a January 2006 publication published two studies that linked the drug's use to kidney damage, heart attacks and strokes. One of those studies previously was withheld by Bayer from the FDA due to what a company investigation later characterized as a "regrettable human error."

Trasylol is used to stop bleeding during heart bypass surgery. Since most bypass patients don't know which drugs are given to them during surgery, most Trasylol patients are unaware that they received the drug. The drug has been the subject of much debate after a January 2006 publication published two studies that linked the drug's use to kidney damage, heart attacks and strokes. However, it wasn't until a recent Candian study confirmed the drug's link to these side effects that the FDA and Bayer took action and stopped the sale of this dangerous drug.

Legal Help is Available

If you or a loved one was injured by Trasylol you may have valuable legal rights. Mark & Associates, P.C. is evaluating cases involving heart bypass patients who suffered kidney damage or other side effects after their surgery. Many bypass patients do not know who medication was used during their surgery. Even if you don't know if Trasylol was used during your surgery Mark & Associates, P.C. will evaluate your case for free.

Please complete a Case Evaluation submission form on this page or call 1-866-50-RIGHTS (1-866-507-4448) for a free consultiation.

Trasylol on 60 Minutes - 1000 Lives a Month

How much did Bayer know? And why did it take Bayer and the U.S. Food and Drug Administration nearly two years to take the drug off the market after major studies revealed the danger? Two years - during which it's estimated Trasylol was contributing to the loss of one thousand lives a month.